US equities |
MU $1,088.00 ▲+0.00% SNDK $1,692.42 ▲+0.00% NVDA $237.47 ▲+0.00% INTC $113.12 ▲+0.00% AMD $645.86 ▲+0.00% MSTR $153.37 ▲+0.00% SPCX $167.60 ▲+0.00% SKHY $178.25 ▲+0.00%
FinancialContent

Latest News about Andrew Chadeayne

Recent news which mentions Andrew Chadeayne

FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
Tickers CMPS NEWS
Tags Top Stories Psychedelic Therapy psilocin
From Benzinga
CaamTech Raises $22M With A Broad Portfolio Of Novel Psychedelic Drugs
Tags Noetic CaaMTech Andrew Chadeayne
From Benzinga